Clomiphene

• 

  Subject Areas on Research

  • Altering hirsutism through ovulation induction in women with polycystic ovary syndrome. 
  • Anti-estrogenic compounds increase prolactin and growth hormone synthesis in clonal strains of rat pituitary cells. 
  • Clomifene and Assisted Reproductive Technology in Humans Are Associated with Sex-Specific Offspring Epigenetic Alterations in Imprinted Control Regions. 
  • Clomiphene citrate in the management of male hypofertility: predictors for treatment selection. 
  • Clomiphene citrate in the management of male infertility. 
  • Clomiphene citrate: pharmacologic treatment of hypofertile male. 
  • Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. 
  • Comparison of intracervical, intrauterine, and intratubal techniques for donor insemination. 
  • Comparison of low-technology and high-technology monitoring of clomiphene citrate ovulation induction. 
  • Cortisone acetate versus clomiphene citrate in per-germinal idiopathic oligospermia. 
  • Does progesterone supplementation improve pregnancy rates in clomiphene citrate and intrauterine insemination treatment cycles? 
  • Endocrine dysfunction and clomiphene citrate therapy. 
  • Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. 
  • Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer. 
  • Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial. 
  • Estrogen and progesterone production by granulosa cell monolayers derived from in vitro fertilization procedures: lack of evidence for modulation by androgen. 
  • Estrogen modulation of nuclear matrix-associated steroid hormone binding. 
  • Evidence-based treatments for couples with unexplained infertility: a guideline. 
  • Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome. 
  • Fertility treatment is associated with multiple meningiomas and younger age at diagnosis. 
  • Hypofertility and clomiphene citrate therapy. 
  • Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome (PPCOS) Trial. 
  • Luteal support with both estradiol and progesterone after clomiphene citrate stimulation for in vitro fertilization. 
  • Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome Trial. 
  • Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome. 
  • Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited. 
  • Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist. 
  • Poor Endometrial Proliferation After Clomiphene is Associated With Altered Estrogen Action. 
  • Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. 
  • Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women. 
  • Staging profile of hypofertile male subjects. 
  • Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract. 
  • The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. 
  • Treatment-independent, treatment-associated, and pregnancies after additional therapy in a program of in vitro fertilization and embryo transfer. 
  • Use of human cumulus granulosa cells for in vitro screening of reproductive toxicants.